109 related articles for article (PubMed ID: 6864523)
1. Release of norepinephrine from organ-cultured superior cervical ganglia: effects of the norepinephrine uptake inhibitor xylamine.
Fischer JB; Cho AK
J Pharmacol Exp Ther; 1983 Jun; 225(3):623-9. PubMed ID: 6864523
[TBL] [Abstract][Full Text] [Related]
2. Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
Fischer JB; Waggaman LA; Ransom RW; Cho AK
J Pharmacol Exp Ther; 1983 Sep; 226(3):650-5. PubMed ID: 6887005
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of [3H]norepinephrine uptake in organ cultured rat superior cervical ganglia by xylamine.
Fischer JB; Cho AK
J Pharmacol Exp Ther; 1982 Jan; 220(1):115-9. PubMed ID: 7053407
[TBL] [Abstract][Full Text] [Related]
4. The effects of xylamine, a nitrogen mustard on [3H]norepinephrine accumulation in rabbit aorta.
Cho AK; Ransom RW; Fischer JB; Kammerer RC
J Pharmacol Exp Ther; 1980 Aug; 214(2):324-7. PubMed ID: 7391980
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study.
Howard-Butcher S; Blaha CD; Lane RF
J Pharmacol Exp Ther; 1985 Apr; 233(1):58-63. PubMed ID: 3981462
[TBL] [Abstract][Full Text] [Related]
6. In vitro release of 3H-noradrenaline by amphetamine from the superior cervical ganglion of the cat.
Filinger EJ; Stefano FJ
Acta Physiol Lat Am; 1981; 31(2):105-11. PubMed ID: 7187584
[TBL] [Abstract][Full Text] [Related]
7. Effects of xylamine on vascular neuroeffector transmission.
Nedergaard OA; Cho AK; Waggaman LA
J Pharmacol Exp Ther; 1992 Jul; 262(1):231-7. PubMed ID: 1625202
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of xylamine on the uptake of [3H]norepinephrine into primary astrocyte cultures.
Chang TK; Cheng JT
Brain Res; 1992 Nov; 597(1):162-5. PubMed ID: 1477731
[TBL] [Abstract][Full Text] [Related]
9. Modulatory role of alpha adrenoceptors on the release of [3H]norepinephrine elicited by preganglionic stimulation of the cat superior cervical ganglion.
Martínez AE; Adler-Graschinsky E
J Pharmacol Exp Ther; 1980 Mar; 212(3):533-5. PubMed ID: 6102146
[TBL] [Abstract][Full Text] [Related]
10. A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degeneration.
Dudley MW; Siegel BW; Ogden AM; McCarty DR
J Pharmacol Exp Ther; 1988 Oct; 247(1):174-9. PubMed ID: 2459367
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of beta-phenylethylamine and d-amphetamine on rat isolated atria.
Pesce G; Adler-Graschinsky E
J Pharmacol Exp Ther; 1983 Oct; 227(1):205-14. PubMed ID: 6555238
[TBL] [Abstract][Full Text] [Related]
12. The peripheral noradrenergic terminal as possible site of action of salsolinol as prolactoliberin.
Székács D; Bodnár I; Mravec B; Kvetnansky R; Vizi ES; Nagy GM; Fekete MI
Neurochem Int; 2007 Jan; 50(2):427-34. PubMed ID: 17141375
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine and neural plasticity: the effects of xylamine on experience-induced changes in brain weight, memory, and behavior.
Benloucif S; Bennett EL; Rosenzweig MR
Neurobiol Learn Mem; 1995 Jan; 63(1):33-42. PubMed ID: 7663878
[TBL] [Abstract][Full Text] [Related]
14. Chemical transformations of xylamine (N-2'-chloroethyl-N-ethyl-2-methylbenzylamine) in solution. Pharmacological activity of the species derived from this irreversible norepinephrine uptake inhibitor.
Ransom RW; Kammerer RC; Cho AK
Mol Pharmacol; 1982 Mar; 21(2):380-6. PubMed ID: 7099142
[TBL] [Abstract][Full Text] [Related]
15. Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic 3',5'-guanosine monophosphate.
Lonart G; Johnson KM
J Pharmacol Exp Ther; 1995 Oct; 275(1):14-22. PubMed ID: 7562542
[TBL] [Abstract][Full Text] [Related]
16. Specificity of amphetamine induced release of norepinephrine and serotonin from rat brain in vitro.
Ziance RJ
Res Commun Chem Pathol Pharmacol; 1977 Dec; 18(4):627-44. PubMed ID: 928960
[TBL] [Abstract][Full Text] [Related]
17. Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activity.
Feigenbaum J; Yanai J; Klawans H; Moon B
Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):349-52. PubMed ID: 6844751
[TBL] [Abstract][Full Text] [Related]
18. The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
Dudley MW
Life Sci; 1988; 43(23):1871-7. PubMed ID: 3143879
[TBL] [Abstract][Full Text] [Related]
19. Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. I. The role of glutamate.
Lonart G; Johnson KM
J Pharmacol Exp Ther; 1995 Oct; 275(1):7-13. PubMed ID: 7562597
[TBL] [Abstract][Full Text] [Related]
20. Effects of phenylethanolamine N-methyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain.
Liang NY; Hower JA; Borchardt RT
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):467-70. PubMed ID: 4059661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
